{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:57:07Z","timestamp":1776873427126,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Academic Clincal Fellow"],"award-info":[{"award-number":["Academic Clincal Fellow"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Academic Clinical Fellow"],"award-info":[{"award-number":["Academic Clinical Fellow"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12687-019-00419-6","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:30:26Z","timestamp":1557160226000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2332-5452","authenticated-orcid":false,"given":"Siang Ing","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Luveta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"issue":"4","key":"419_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/GIM.0b013e3181d56ae6","volume":"12","author":"Louise S Acheson","year":"2010","unstructured":"Acheson LS, Wang C, Zyzanski SJ, Lynn A, Ruffin MT 4th, Gramling R, Rubinstein WS, O'Neill SM, Nease de Jr, Family Healthware Impact Trial (FHITr) Group (2010) Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med 12:212\u2013218. \nhttps:\/\/doi.org\/10.1097\/GIM.0b013e3181d56ae6","journal-title":"Genetics in Medicine"},{"key":"419_CR2","doi-asserted-by":"publisher","unstructured":"Carbine NE, Lostumbo L, Wallace J, Ko H (2018) Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev (4):CD002748. \nhttps:\/\/doi.org\/10.1002\/14651858.CD002748.pub4","DOI":"10.1002\/14651858.CD002748.pub4"},{"issue":"4","key":"419_CR3","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.3747\/co.25.4042","volume":"25","author":"JE Cleophat","year":"2018","unstructured":"Cleophat JE, Nabi H, Pelletier S, Bouchard K, Dorval M (2018) What characterizes cancer family history collection tools? A critical literature review. Curr Oncol 25(4):e335\u2013e350. \nhttps:\/\/doi.org\/10.3747\/co.25.4042","journal-title":"Curr Oncol"},{"issue":"9880","key":"419_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","volume":"381","author":"J Cuzick","year":"2013","unstructured":"Cuzick J, Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix A, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL, SERM Chemoprevention of Breast Cancer Overview Group (2013) Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381(9880):1827\u20131834. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)60140-3","journal-title":"Lancet"},{"issue":"9","key":"419_CR5","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967\u2013975. \nhttps:\/\/doi.org\/10.1001\/jama.2010.1237","journal-title":"JAMA"},{"issue":"11","key":"419_CR6","doi-asserted-by":"publisher","first-page":"vii","DOI":"10.3310\/hta17110","volume":"17","author":"SW Duffy","year":"2013","unstructured":"Duffy SW, Mackay J, Thomas S, Anderson E, Chen THH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, Warren R, Watson E, Whynes D, Allgood P, Caunt J (2013) Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess 17(11):vii\u2013xiv, 1-95. \nhttps:\/\/doi.org\/10.3310\/hta17110","journal-title":"Health Technol Assess"},{"issue":"4","key":"419_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.bjc.6603897","volume":"97","author":"J Emery","year":"2007","unstructured":"Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL (2007) The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 97(4):486\u2013493. \nhttps:\/\/doi.org\/10.1038\/sj.bjc.6603897","journal-title":"Br J Cancer"},{"issue":"1","key":"419_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/annonc\/mdm414","volume":"19","author":"K Hemminki","year":"2008","unstructured":"Hemminki K, Sundquist J, Bermejo JL (2008) How common is familial cancer? Ann Oncol 19(1):163\u2013167. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdm414","journal-title":"Ann Oncol"},{"key":"419_CR9","unstructured":"Higgins JPT, Green S. (eds). (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. \nhttps:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"419_CR11","doi-asserted-by":"publisher","unstructured":"Hilgart JS, Coles B, Iredale R (2012) Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Syst Rev (2):CD003721. \nhttps:\/\/doi.org\/10.1002\/14651858.CD003721.pub3","DOI":"10.1002\/14651858.CD003721.pub3"},{"key":"419_CR12","unstructured":"International Standard Randomised Controlled Trials Number (ISRCTN) Registry. (2014) Proactive familial breast cancer risk assessment in primary care (phase 2). \nhttp:\/\/www.isrctn.com\/ISRCTN16117197\n\n. Accessed 10th October 2018"},{"issue":"5","key":"419_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","volume":"118","author":"HJ J\u00e4rvinen","year":"2000","unstructured":"J\u00e4rvinen HJ, Aarnio M, Mustonen H, Aktan\u2013Collan K, Aaltonen LA, Peltom\u00e4ki P, Chapelle ADL, Mecklin J\u2013P (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829\u2013834","journal-title":"Gastroenterology"},{"issue":"9","key":"419_CR14","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/cncr.20989","volume":"103","author":"RA Kerber","year":"2005","unstructured":"Kerber RA, O'Brien E (2005) A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103(9):1906\u20131915. \nhttps:\/\/doi.org\/10.1002\/cncr.20989","journal-title":"Cancer"},{"key":"419_CR15","first-page":"27","volume":"22","author":"S Naicker","year":"2013","unstructured":"Naicker S, Meiser B, Goodwin A et al (2013) Which tests is best? A randomised controlled trial to evaluate the use of familial phenotype to risk appropriately screen for colorectal cancer in the general population. Psycho-Oncology 22:27","journal-title":"Psycho-Oncology"},{"key":"419_CR16","unstructured":"National Institute for Health and Care Excellence (NICE). (2017) Familial breast cancer: classification care and managing breast cancer and related risks in people with a family history of breast cancer [CG164]. NICE, London"},{"key":"419_CR17","unstructured":"NHS England. (2013) Transforming primary care in London: general practice a call to action. NHS England, London. \nhttps:\/\/www.england.nhs.uk\/london\/wp-content\/uploads\/sites\/8\/2013\/11\/Call-Action-ACCESSIBLE.pdf\n\n Accessed 16th October 2018"},{"issue":"6","key":"419_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.amepre.2009.03.002","volume":"36","author":"Suzanne M. O'Neill","year":"2009","unstructured":"O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT 4th, Family Healthware Impact Trial group (2009) Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med 36(6):506\u2013514. \nhttps:\/\/doi.org\/10.1016\/j.amepre.2009.03.002","journal-title":"American Journal of Preventive Medicine"},{"key":"419_CR19","doi-asserted-by":"publisher","unstructured":"Orlando LA, Hauser ER, Christianson C, Powell KP, Buchanan AH, Chesnut B, Agbaje AB, Henrich VC, Ginsburg G (2011) Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system. BMC Health Serv Res 11(264). \nhttps:\/\/doi.org\/10.1186\/1472-6963-11-264","DOI":"10.1186\/1472-6963-11-264"},{"issue":"3","key":"419_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/pme.13.20","volume":"10","author":"LA Orlando","year":"2013","unstructured":"Orlando LA, Henrich VC, Hauser ER, Wilson C, Ginsburg GS (2013) Genomedical connection. The genomic medicine model: an integrated approach to implementation of family health history in primary care. Per Med 10(3):295\u2013306. \nhttps:\/\/doi.org\/10.2217\/pme.13.20","journal-title":"Per Med"},{"issue":"1","key":"419_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.c.31388","volume":"166C","author":"LA Orlando","year":"2014","unstructured":"Orlando LA, Wu RR, Beadles C, Himmel T, Buchanan AH, Powell KP, Hauser ER, Henrich VC, Ginsburg GS (2014) Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand. Am J Med Genet C Semin Med Genet 166C(1):24\u201333. \nhttps:\/\/doi.org\/10.1002\/ajmg.c.31388","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"419_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/gim.2015.210","volume":"18","author":"LA Orlando","year":"2016","unstructured":"Orlando LA, Wu RR, Myers RA, Buchanan AH, Henrich VC, Hauser ER, Ginsburg GS (2016) Clinical utility of a Web-enabled risk-assessment and clinical decision support program. Genet Med 18(10):1020\u20131028. \nhttps:\/\/doi.org\/10.1038\/gim.2015.210","journal-title":"Genet Med"},{"issue":"suppl 5","key":"419_CR23","doi-asserted-by":"publisher","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","volume":"27","author":"S Paluch-Shimon","year":"2016","unstructured":"Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E, ESMO Guidelines Committee (2016) Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol 27(suppl 5):v103\u2013v110. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdw327","journal-title":"Ann Oncol"},{"issue":"5","key":"419_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli N, Daly MB, Feldman GL (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med 12(5):245\u2013259. \nhttps:\/\/doi.org\/10.1097\/GIM.0b013e3181d38f2f","journal-title":"Genet Med"},{"key":"419_CR25","unstructured":"Preventive Services Task Force US (2015) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: recommendation statement. Am Fam Physician 91(2)"},{"key":"419_CR26","unstructured":"PROSPERO (2017) International prospective register of systematic review. \nhttps:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=83418\n\n Accessed 26th September 2017"},{"key":"419_CR27","unstructured":"Qureshi N, Wilson B, Santaguida P et al (2007) Collection and use of cancer family history in primary care. Evidence Report\/Technology Assessment No. 159. AHRQ Publication No. 08-E001. Agency for Healthcare Research and Quality, Rockville, MD"},{"issue":"7","key":"419_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/GIM.0b013e3181a7e8e0","volume":"11","author":"N Qureshi","year":"2009","unstructured":"Qureshi N, Carroll JC, Wilson B, Santaguida P, Allanson J, Brouwers M, Raina P (2009) The current state of cancer family history collection tools in primary care: a systematic review. Genet Med 11(7):495\u2013506. \nhttps:\/\/doi.org\/10.1097\/GIM.0b013e3181a7e8e0","journal-title":"Genet Med"},{"issue":"11","key":"419_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/GIM.0b013e3182241d88","volume":"13","author":"Wendy S. Rubinstein","year":"2011","unstructured":"Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT 4th, Wang C, Beaumont JL, Rothrock N, Family Healthware Impact Trial (FHITr) Group (2011a) Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 13(11):956\u2013965. \nhttps:\/\/doi.org\/10.1097\/GIM.0b013e3182241d88","journal-title":"Genetics in Medicine"},{"issue":"1","key":"419_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/GIM.0b013e3181fbe485","volume":"13","author":"WS Rubinstein","year":"2011","unstructured":"Rubinstein WS, O'Neill SM, Rothrock N, Starzyk EJ, Beaumont JL, Acheson LS, Wang C, Gramling R, Galliher JM, Ruffin MT (2011b) Components of family history associated with women's disease perceptions for cancer: a report from the Family HealthwareTM Impact Trial. Genet Med 13(1):52\u201362. \nhttps:\/\/doi.org\/10.1097\/GIM.0b013e3181fbe485","journal-title":"Genet Med"},{"issue":"1","key":"419_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1370\/afm.1197","volume":"9","author":"MT Ruffin","year":"2011","unstructured":"Ruffin MT, Nease DE Jr, Sen A et al (2011) Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med 9(1):3\u201311. \nhttps:\/\/doi.org\/10.1370\/afm.1197","journal-title":"Ann Fam Med"},{"issue":"11","key":"419_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/GIM.0b013e3181f30e9e","volume":"12","author":"MT Scheuner","year":"2010","unstructured":"Scheuner MT, McNeel TS, Freedman AN (2010) Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med 12(11):726\u2013735. \nhttps:\/\/doi.org\/10.1097\/GIM.0b013e3181f30e9e","journal-title":"Genet Med"},{"key":"419_CR33","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A. (eds) (2013) GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group, 2013"},{"key":"419_CR34","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, the PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647","journal-title":"BMJ"},{"key":"419_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. \nhttps:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"419_CR36","unstructured":"UK Biobank. (2007) Protocol for a large-scale prospective epidemiological resource. \nhttp:\/\/www.ukbiobank.ac.uk\/wp-content\/uploads\/2011\/11\/UK-Biobank-Protocol.pdf\n\n Accessed 10th October 2018"},{"key":"419_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2017.03.014","volume":"78","author":"A Van Erkelens","year":"2017","unstructured":"Van Erkelens A, Sie AS, Manders P et al (2017) Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress. Eur J Cancer 78:45\u201352. \nhttps:\/\/doi.org\/10.1016\/j.ejca.2017.03.014","journal-title":"Eur J Cancer"},{"key":"419_CR38","unstructured":"Voils C (2017) Impact of family history and decision support on high-risk cancer screening. \nClinicalTrials.gov\n\n. \nhttps:\/\/clinicaltrials.gov\/show\/NCT02247336\n\n Accessed 10th October 2018"},{"issue":"5","key":"419_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1370\/afm.1837","volume":"13","author":"JG Walker","year":"2015","unstructured":"Walker JG, Licqurish S, Chiang PPC, Pirotta M, Emery JD (2015) Cancer risk assessment tools in primary care: a systematic review of randomized controlled trials. Ann Fam Med 13(5):480\u2013489. \nhttps:\/\/doi.org\/10.1370\/afm.1837","journal-title":"Ann Fam Med"},{"issue":"4","key":"419_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.amepre.2012.06.013","volume":"43","author":"C Wang","year":"2012","unstructured":"Wang C, Sen A, MTt R et al (2012) Family history assessment. impact on disease risk perceptions Am J Prev Med 43(4):392\u2013398. \nhttps:\/\/doi.org\/10.1016\/j.amepre.2012.06.013","journal-title":"impact on disease risk perceptions Am J Prev Med"},{"key":"419_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ypmed.2015.04.007","volume":"77","author":"C Wang","year":"2015","unstructured":"Wang C, Sen A, Plegue M, Ruffin MT IV, O'Neill SM, Rubinstein WS, Acheson LS, Yoon PW, Valdez R, Irizarry-de la Cruz M, Khoury MJ, Jorgensen C, Scheuner MT, Rubinstein WS, O'Neill SM, Rothrock N, Beaumont JL, Khan S, Ali D, Ruffin MT, Nease D, Acheson LS, Zyzanski SJ, Wiesner GL, Werner J, Pace WD, Galliher JM, Brandt E, Wang C, Gramling R, Starzyk EJ (2015) Impact of family history assessment on communication with family members and health care providers: a report from the Family Healthware Impact Trial (FHITr). Prev Med 77:28\u201334. \nhttps:\/\/doi.org\/10.1016\/j.ypmed.2015.04.007","journal-title":"Prev Med"},{"issue":"3","key":"419_CR42","first-page":"iii","volume":"9","author":"BJ Wilson","year":"2005","unstructured":"Wilson BJ, Torrance N, Mollison J et al (2005) Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. Health Technology Assessment (Winchester, England) 9(3):iii\u2013iv, 1-12","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"5","key":"419_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/fampra\/cml026","volume":"23","author":"BJ Wilson","year":"2006","unstructured":"Wilson BJ, Torrance N, Mollison J, Watson MS, Douglas A, Miedzybrodzka Z, Gordon R, Wordsworth S, Campbell M, Haites N, Grant A (2006) Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk. Fam Pract 23(5):537\u2013544. \nhttps:\/\/doi.org\/10.1093\/fampra\/cml026","journal-title":"Fam Pract"},{"key":"419_CR44","unstructured":"World Cancer Research Fund. Worldwide cancer data: global cancer statistics for the most common cancers. \nhttps:\/\/www.wcrf.org\/dietandcancer\/cancer-trends\/worldwide-cancer-data\n\n Accessed 23rd October 2018"},{"key":"419_CR45","doi-asserted-by":"publisher","unstructured":"Wu RR, Orlando LA, Himmel TL, Buchanan AH, Powell KP, Hauser ER, Agbaje AB, Henrich VC, Ginsburg GS (2013) Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial. BMC Fam Pract 14(111). \nhttps:\/\/doi.org\/10.1186\/1471-2296-14-111","DOI":"10.1186\/1471-2296-14-111"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-019-00419-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12687-019-00419-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-019-00419-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:30:40Z","timestamp":1588635040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12687-019-00419-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s12687-019-00419-6","relation":{},"ISSN":["1868-310X","1868-6001"],"issn-type":[{"value":"1868-310X","type":"print"},{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"7 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Nadeem Qureshi is a member of the NICE Guideline Development Group for Familial Breast Cancer and the Advisory Board for Journal of Community Genetics. Siang Ing Lee, Mitesh Patel, Brittany Dutton, Stephen Weng and Jocelyn Luveta declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}